Matches in SemOpenAlex for { <https://semopenalex.org/work/W2049153208> ?p ?o ?g. }
- W2049153208 endingPage "4134" @default.
- W2049153208 startingPage "4122" @default.
- W2049153208 abstract "Amonafide (1), a naphthalimide which binds to DNA by intercalation and poisons topoisomerase IIα, has demonstrated activity in phase II breast cancer trials, but has failed thus far to enter clinical phase III because of dose-limiting bone marrow toxicity. Compound 17 (one of 41 new compounds synthesized) is a novel anticancer naphthalimide with a distinct mechanism of action, notably inducing autophagy and senescence in cancer cells. Compound 17 (2,2,2-trichloro-N-({2-[2-(dimethylamino)ethyl]-1,3-dioxo-2,3-dihydro-1H-benzo[de]isoquinolin-5-yl}carbamoyl)acetamide (UNBS3157)) was found to have a 3−4-fold higher maximum tolerated dose compared to amonafide and not to provoke hematotoxicity in mice at doses that display significant antitumor effects. Furthermore, 17 has shown itself to be superior to amonafide in vivo in models of (i) L1210 murine leukemia, (ii) MXT−HI murine mammary adenocarcinoma, and (iii) orthotopic models of human A549 NSCLC and BxPC3 pancreatic cancer. Compound 17, therefore, merits further investigation as a potential anticancer agent." @default.
- W2049153208 created "2016-06-24" @default.
- W2049153208 creator A5011751499 @default.
- W2049153208 creator A5012759206 @default.
- W2049153208 creator A5016418584 @default.
- W2049153208 creator A5033613763 @default.
- W2049153208 creator A5037491019 @default.
- W2049153208 creator A5040188855 @default.
- W2049153208 creator A5046581462 @default.
- W2049153208 creator A5048006451 @default.
- W2049153208 creator A5050210411 @default.
- W2049153208 creator A5050607285 @default.
- W2049153208 creator A5051262076 @default.
- W2049153208 creator A5052824554 @default.
- W2049153208 creator A5063658406 @default.
- W2049153208 creator A5073165497 @default.
- W2049153208 creator A5080197947 @default.
- W2049153208 date "2007-07-21" @default.
- W2049153208 modified "2023-09-29" @default.
- W2049153208 title "2,2,2-Trichloro-<i>N</i>-({2-[2-(dimethylamino)ethyl]-1,3-dioxo-2,3-dihydro-1<i>H</i>-benzo[de]isoquinolin- 5-yl}carbamoyl)acetamide (UNBS3157), a Novel Nonhematotoxic Naphthalimide Derivative with Potent Antitumor Activity" @default.
- W2049153208 cites W1898204010 @default.
- W2049153208 cites W1964420727 @default.
- W2049153208 cites W1965724874 @default.
- W2049153208 cites W1970028441 @default.
- W2049153208 cites W1972940377 @default.
- W2049153208 cites W1993643473 @default.
- W2049153208 cites W2005142336 @default.
- W2049153208 cites W2024209230 @default.
- W2049153208 cites W2025909270 @default.
- W2049153208 cites W2030647991 @default.
- W2049153208 cites W2031594074 @default.
- W2049153208 cites W2034660754 @default.
- W2049153208 cites W2046694427 @default.
- W2049153208 cites W2047569768 @default.
- W2049153208 cites W2049856484 @default.
- W2049153208 cites W2055793916 @default.
- W2049153208 cites W2056657908 @default.
- W2049153208 cites W2061250423 @default.
- W2049153208 cites W2065796293 @default.
- W2049153208 cites W2066984650 @default.
- W2049153208 cites W2069499604 @default.
- W2049153208 cites W2078017356 @default.
- W2049153208 cites W2081568246 @default.
- W2049153208 cites W2085753859 @default.
- W2049153208 cites W2085925430 @default.
- W2049153208 cites W2086892948 @default.
- W2049153208 cites W2087398360 @default.
- W2049153208 cites W2092828898 @default.
- W2049153208 cites W2094992186 @default.
- W2049153208 cites W2096287682 @default.
- W2049153208 cites W2102062162 @default.
- W2049153208 cites W2104908670 @default.
- W2049153208 cites W2118513443 @default.
- W2049153208 cites W2125353417 @default.
- W2049153208 cites W2130294703 @default.
- W2049153208 cites W2163882233 @default.
- W2049153208 cites W2166022410 @default.
- W2049153208 cites W2167526365 @default.
- W2049153208 cites W2168715841 @default.
- W2049153208 doi "https://doi.org/10.1021/jm070315q" @default.
- W2049153208 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17658777" @default.
- W2049153208 hasPublicationYear "2007" @default.
- W2049153208 type Work @default.
- W2049153208 sameAs 2049153208 @default.
- W2049153208 citedByCount "114" @default.
- W2049153208 countsByYear W20491532082012 @default.
- W2049153208 countsByYear W20491532082013 @default.
- W2049153208 countsByYear W20491532082014 @default.
- W2049153208 countsByYear W20491532082015 @default.
- W2049153208 countsByYear W20491532082016 @default.
- W2049153208 countsByYear W20491532082017 @default.
- W2049153208 countsByYear W20491532082018 @default.
- W2049153208 countsByYear W20491532082019 @default.
- W2049153208 countsByYear W20491532082020 @default.
- W2049153208 countsByYear W20491532082021 @default.
- W2049153208 countsByYear W20491532082022 @default.
- W2049153208 countsByYear W20491532082023 @default.
- W2049153208 crossrefType "journal-article" @default.
- W2049153208 hasAuthorship W2049153208A5011751499 @default.
- W2049153208 hasAuthorship W2049153208A5012759206 @default.
- W2049153208 hasAuthorship W2049153208A5016418584 @default.
- W2049153208 hasAuthorship W2049153208A5033613763 @default.
- W2049153208 hasAuthorship W2049153208A5037491019 @default.
- W2049153208 hasAuthorship W2049153208A5040188855 @default.
- W2049153208 hasAuthorship W2049153208A5046581462 @default.
- W2049153208 hasAuthorship W2049153208A5048006451 @default.
- W2049153208 hasAuthorship W2049153208A5050210411 @default.
- W2049153208 hasAuthorship W2049153208A5050607285 @default.
- W2049153208 hasAuthorship W2049153208A5051262076 @default.
- W2049153208 hasAuthorship W2049153208A5052824554 @default.
- W2049153208 hasAuthorship W2049153208A5063658406 @default.
- W2049153208 hasAuthorship W2049153208A5073165497 @default.
- W2049153208 hasAuthorship W2049153208A5080197947 @default.
- W2049153208 hasConcept C147897179 @default.
- W2049153208 hasConcept C150903083 @default.
- W2049153208 hasConcept C178790620 @default.
- W2049153208 hasConcept C185592680 @default.
- W2049153208 hasConcept C202751555 @default.